IP Library Granted Patent US 12,343,416
Granted Patent B2
US 12,343,416 · App. 17/432,333 · Granted Jul 1, 2025

Skin engaging member for razor cartridge comprising skin active ingredient

Inventor: Athanasia Panou (Agiou Athanasiou, GR)
Assignee: BIC-VIOLEX S.A.
A61K8/36A61Q9/02
View Patent ↗
Loading inventors, assignments & file history…
Monitor This Case
Get email alerts when status or documents change.
Order Certified Copies
Most orders are placed with the USPTO same day — all within 24 business hours.
Order via The Patent Place →
Pre-filled with this patent's details
Quick Facts
Patent No.
US 12,343,416
App. No.
17/432,333
Granted
Jul 1, 2025
Kind
B2
Abstract

A skin engaging member is attached to a razor cartridge. The skin engaging member includes a water-insoluble material and a water-soluble material. The skin engaging member also includes a thermally tolerant skin active ingredient capable of treating and/or preventing skin redness or skin irritation. The skin active ingredient can be at least one terpenic acid derivative or its salts, strombine or a salt of strombine combined with a clay, and mixtures thereof.

Claims (21)

1. A process for manufacturing a skin engaging member, wherein the process comprises:

extruding, injection-molding, laminating, or compression-molding a composition at a processing temperature from 150° C. to 300° C. while at a pressure from 250 bar to 2000 bar into the skin engaging member; and

incorporating the skin engaging member on a razor cartridge,

wherein the composition comprises at least a water-soluble material, a water-insoluble material, and a skin active ingredient that is thermally tolerant and capable of treating and/or preventing skin redness or skin irritation,

wherein the skin active ingredient is selected from the group consisting of strombine combined with a clay, and a salt of strombine combined with a clay.

2. The process according to claim 1 , wherein the salt of strombine is selected from the group consisting of: sodium, disodium, ammonium, lithium, magnesium, calcium, manganese, silver, and alkali metal salts.

3. The process according to claim 1 , wherein the clay is selected from the group consisting of: kaolinite, montmorillonite, smectite, illite, chlorite, bentonite, any other suitable carrier/inert vector, and any mixtures thereof.

4. The process according to claim 1 , wherein the skin engaging member comprises from 0.001 to about 10% of the skin active ingredient, by weight relative to a total weight of the skin engaging member.

5. The process according to claim 1 , wherein the skin engaging member comprises from 10% to 100% of water-insoluble material by weight relative to a total weight of the skin engaging member, from 0.001% to 90% of water-soluble material by weight relative to the total weight of the skin engaging member, and/or from 0.001% to 15% of other ingredients by weight relative to the total weight of the skin engaging member.

6. The process according to claim 1 , wherein the water-insoluble material comprises rigid water-insoluble material or elastic water-insoluble material, or a combination thereof.

7. The process according to claim 1 , wherein the water-insoluble material comprises a rigid water-insoluble material selected from the group consisting of: polystyrene, styrene co-polymers, polyethylene, polypropylene, polyacetal, acrylonitrile-butadiene-styrene copolymer, ethylene vinyl acetal copolymer, polylactic acid, polycarbonate, maleic anhydride ethylene co-polymer blends, polyether-containing block copolymers, and any mixtures and any copolymers thereof.

8. The process according to claim 1 , wherein the water-soluble material comprises a material selected from the group consisting of: polyethylene oxide, polyethylene glycol, polyvinyl pyrrolidone, polyacrylamide, polyhydromethymethacrylate, and any mixtures thereof, and any copolymers thereof.

9. The process according to claim 1 , further comprising:

blending, prior to the extruding, injection-molding, laminating, or compression-molding, the water-soluble material, the water-insoluble material, and the skin active ingredient into a blended composition.

10. The process according to claim 9 , further comprising:

drying, after the blending, the blended composition into pellets; and

melting the pellets prior to the extruding, injection-molding, laminating, or compression-molding.

11. The process according to claim 9 , wherein the composition is co-injected with the razor cartridge.

12. The process according to claim 1 , wherein the skin active ingredient is a salt of strombine combined with a clay, and wherein the skin engaging member comprises 0.5% to 4% of the skin active ingredient by weight relative to the total weight of the skin engaging member.

13. The process according to claim 1 , wherein the water-soluble material is a lubricating polymer, and wherein the process further comprises: dispersing the lubricating polymer in the water-insoluble material to form an immiscible blend.

14. The process according to claim 13 , wherein the lubricating polymer is polyethylene glycol (PEG) or polyethylene oxide and the water-insoluble material is high impact polystyrene (HIPS).

Assignments (2)
CHANGE OF NAME Recorded Aug 21, 2023
From: BIC VIOLEX S.A.
To: BIC VIOLEX SINGLE MEMBER S.A.
Reel/Frame 066511/0676 →
ASSIGNMENT OF ASSIGNOR'S INTEREST Recorded Aug 19, 2021
From: PANOU, ATHANASIA
To: BIC VIOLEX S.A.
Reel/Frame 057232/0355 →
Priority Claims (1)
EP 19305238 · Feb 28, 2019 · regional
Continuity (1)
Related Publication 20220151891A1 · May 19, 2022
References Cited (25)
US 5692302A · Booth et al. · 1997 [cited by applicant]
US 6589516B1 · Eyre et al. · 2003 [cited by applicant]
US 9675531B2 · Gonzales · 2017 [cited by examiner]
US 20040132667A1 · Lintner · 2004 [cited by applicant]
US 20120216408A1 · Cook · 2012 [cited by examiner]
US 20130042482A1 · Bradford et al. · 2013 [cited by applicant]
US 20140090254A1 · Bakes et al. · 2014 [cited by applicant]
US 20140090255A1 · Bakes et al. · 2014 [cited by applicant]
US 20140230839A1 · Coffindaffer et al. · 2014 [cited by applicant]
US 20150273711A1 · Bradford et al. · 2015 [cited by applicant]
US 20160008297A1 · Haustedt et al. · 2016 [cited by applicant]
EP 2900332 · 2015 [cited by applicant]
EP 2900333 · 2015 [cited by applicant]
WO 9613360 · 1996 [cited by applicant]
WO 0057893 · 2000 [cited by applicant]
WO 2008150155 · 2008 [cited by applicant]
WO 2012009298 · 2012 [cited by applicant]
WO WO2012009298A2 · 2012 [cited by examiner]
WO 2014052389 · 2014 [cited by applicant]
WO 2014052390 · 2014 [cited by applicant]
WO 2016016582 · 2016 [cited by applicant]
WO WO2016016582A1 · 2016 [cited by examiner]
WO-2016016582-A1 translation from French, provided by applicant (Year: 2021). [cited by examiner]
International Search Report dated Apr. 6, 2020 in corresponding International PCT Patent Application No. PCT/EP2020/055334, 5 pgs. [cited by applicant]
Written Opinion dated Apr. 6, 2020 in corresponding International PCT Patent Application No. PCT/EP2020/055334, 8 pgs. [cited by applicant]